Sebastian Amigorena

Scientific Advisory Board

Sebastian Amigorena, Ph.D.

Member of the French Academy of Sciences & Director of Immunology Department (INSERM U932, “Cancer Immunity”), Curie Institute, Paris, France.

Back

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn